Compare $BBNX vs $CBLL | Chartloom

Compare

$BBNX vs $CBLL

Beta Bionics Inc · Ceribell Inc

BBNX

Beta Bionics Inc

CBLL

Ceribell Inc

Compare $BBNX vs $CBLL

Comparing Beta Bionics Inc and Ceribell Inc

BBNXBeta Bionics Inc

CBLLCeribell Inc

BBNXBeta Bionics Inc

Market cap

$793M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.37x

Rev growth (TTM)

94.1%

YTD performance

-39.7%

52W performance

-20.3%

FCF yield

-7.7%

CBLLCeribell Inc

Market cap

$897M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.72x

Rev growth (TTM)

31.7%

YTD performance

10.9%

52W performance

93.1%

FCF yield

-6.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BBNX

CBLL

Detailed metrics comparison

BBNX

Beta Bionics Inc

CBLL

Ceribell Inc

Market Cap

BBNX$793M

CBLL$897M

Enterprise Value

BBNX$749M

CBLL$884M

Price

BBNX$17.63

CBLL$23.63

P/E Ratio

BBNXN/A

CBLLN/A

P/S Ratio

BBNX6.66x

CBLL8.79x

EV/Sales

BBNX6.29x

CBLL8.67x

EV/EBITDA

BBNX0.00x

CBLL0.00x

P/B Ratio

BBNX3.99x

CBLL7.09x

P/FCF Ratio

BBNXN/A

CBLLN/A

EV/FCF

BBNX-12.19x

CBLL-15.76x

PEG Ratio

BBNXN/A

CBLLN/A

Forward P/E (NTM)

BBNXN/A

CBLLN/A

Forward P/S (NTM)

BBNX5.37x

CBLL6.72x

Revenue (TTM)

BBNX$119M

CBLL$102M

Revenue Growth (YoY)

BBNX94.1%

CBLL31.7%

Forward Rev Growth

BBNX34.2%

CBLL27.3%

Gross Margin (TTM)

BBNX58.3%

CBLL88.9%

Operating Margin (TTM)

BBNX0.0%

CBLL0.0%

EBITDA Margin (TTM)

BBNX-67.9%

CBLL-67.5%

Net Margin (TTM)

BBNX-61.3%

CBLL-64.7%

FCF Margin (TTM)

BBNX-51.6%

CBLL-55.0%

Net Income (TTM)

BBNX$-73M

CBLL$-66M

FCF (TTM)

BBNX$-61M

CBLL$-56M

EPS (TTM)

BBNX-$1.64

CBLL-$1.74

ROE (TTM)

BBNX-2630.0%

CBLL-4485.0%

ROA (TTM)

BBNX-2325.0%

CBLL-3569.0%

ROIC (TTM)

BBNX-2630.0%

CBLL-3952.0%

Cash

BBNX$44M

CBLL$33M

Debt

BBNX$0

CBLL$20M

Net Cash/Debt

BBNX$44M

CBLL$13M

Current Ratio (TTM)

BBNX8.88x

CBLL9.18x

Quick Ratio (TTM)

BBNX7.72x

CBLL8.57x

Debt/Equity (TTM)

BBNX0.00x

CBLL0.16x

Debt/Assets (TTM)

BBNX0.0%

CBLL0.0%

Interest Coverage (TTM)

BBNXN/A

CBLLN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

CBLL0.00x

Beta

BBNX0.92

CBLL0.98

52W Performance

BBNX-20.3%

CBLL93.1%

YTD Performance

BBNX-39.7%

CBLL10.9%

% from 52W High

BBNX-46.1%

CBLL-7.8%

% from 52W Low

BBNX100.3%

CBLL117.8%

Asset Turnover (TTM)

BBNX0.38x

CBLL0.55x

FCF Yield (TTM)

BBNX-7.7%

CBLL-6.3%

Earnings Yield (TTM)

BBNX-9.2%

CBLL-7.4%

Dividend Yield (TTM)

BBNXN/A

CBLLN/A

Rule of 40

BBNX42.5

CBLL-23.3

EV/GP/RG

BBNX0.34

CBLL0.28

Ticker research

View BBNX research View CBLL research

Metric	BBNX Beta Bionics Inc	CBLL Ceribell Inc
Market & Valuation
Market Cap	$793M	$897M
Enterprise Value	$749M	$884M
Price	$17.63	$23.63
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	8.79x
EV/Sales	6.29x	8.67x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.99x	7.09x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.19x	-15.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.37x	6.72x
Revenue & Growth
Revenue (TTM)	$119M	$102M
Revenue Growth (YoY)	94.1%	31.7%
Forward Rev Growth	34.2%	27.3%
Profitability
Gross Margin (TTM)	58.3%	88.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-67.9%	-67.5%
Net Margin (TTM)	-61.3%	-64.7%
FCF Margin (TTM)	-51.6%	-55.0%
Net Income (TTM)	$-73M	$-66M
FCF (TTM)	$-61M	$-56M
EPS (TTM)	-$1.64	-$1.74
ROE (TTM)	-2630.0%	-4485.0%
ROA (TTM)	-2325.0%	-3569.0%
ROIC (TTM)	-2630.0%	-3952.0%
Financial Health
Cash	$44M	$33M
Debt	$0	$20M
Net Cash/Debt	$44M	$13M
Current Ratio (TTM)	8.88x	9.18x
Quick Ratio (TTM)	7.72x	8.57x
Debt/Equity (TTM)	0.00x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	0.98
52W Performance	-20.3%	93.1%
YTD Performance	-39.7%	10.9%
% from 52W High	-46.1%	-7.8%
% from 52W Low	100.3%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.55x
FCF Yield (TTM)	-7.7%	-6.3%
Earnings Yield (TTM)	-9.2%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	-23.3
EV/GP/RG	0.34	0.28
Ticker research	View BBNX research	View CBLL research

Valuation

P/S Ratio

BBNX

6.66x

CBLL

8.79x

EV/FCF

CBLL

-15.76x

BBNX

-12.19x

Growth & revenue

Revenue Growth TTM

BBNX

94.1%

CBLL

31.7%

Forward Revenue Growth

BBNX

34.2%

CBLL

27.3%

Profitability & performance

Gross Margin

CBLL

88.9%

BBNX

58.3%

ROE

BBNX

-2630.0%

CBLL

-4485.0%

FCF Yield %

CBLL

-6.3%

BBNX

-7.7%

52-Week Performance

CBLL

93.1%

BBNX

-20.3%

Detailed metrics comparison

BBNX

Beta Bionics Inc

CBLL

Ceribell Inc

Market Cap

BBNX$793M

CBLL$897M

Enterprise Value

BBNX$749M

CBLL$884M

Price

BBNX$17.63

CBLL$23.63

P/E Ratio

BBNXN/A

CBLLN/A

P/S Ratio

BBNX6.66x

CBLL8.79x

EV/Sales

BBNX6.29x

CBLL8.67x

EV/EBITDA

BBNX0.00x

CBLL0.00x

P/B Ratio

BBNX3.99x

CBLL7.09x

P/FCF Ratio

BBNXN/A

CBLLN/A

EV/FCF

BBNX-12.19x

CBLL-15.76x

PEG Ratio

BBNXN/A

CBLLN/A

Forward P/E (NTM)

BBNXN/A

CBLLN/A

Forward P/S (NTM)

BBNX5.37x

CBLL6.72x

Revenue (TTM)

BBNX$119M

CBLL$102M

Revenue Growth (YoY)

BBNX94.1%

CBLL31.7%

Forward Rev Growth

BBNX34.2%

CBLL27.3%

Gross Margin (TTM)

BBNX58.3%

CBLL88.9%

Operating Margin (TTM)

BBNX0.0%

CBLL0.0%

EBITDA Margin (TTM)

BBNX-67.9%

CBLL-67.5%

Net Margin (TTM)

BBNX-61.3%

CBLL-64.7%

FCF Margin (TTM)

BBNX-51.6%

CBLL-55.0%

Net Income (TTM)

BBNX$-73M

CBLL$-66M

FCF (TTM)

BBNX$-61M

CBLL$-56M

EPS (TTM)

BBNX-$1.64

CBLL-$1.74

ROE (TTM)

BBNX-2630.0%

CBLL-4485.0%

ROA (TTM)

BBNX-2325.0%

CBLL-3569.0%

ROIC (TTM)

BBNX-2630.0%

CBLL-3952.0%

Cash

BBNX$44M

CBLL$33M

Debt

BBNX$0

CBLL$20M

Net Cash/Debt

BBNX$44M

CBLL$13M

Current Ratio (TTM)

BBNX8.88x

CBLL9.18x

Quick Ratio (TTM)

BBNX7.72x

CBLL8.57x

Debt/Equity (TTM)

BBNX0.00x

CBLL0.16x

Debt/Assets (TTM)

BBNX0.0%

CBLL0.0%

Interest Coverage (TTM)

BBNXN/A

CBLLN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

CBLL0.00x

Beta

BBNX0.92

CBLL0.98

52W Performance

BBNX-20.3%

CBLL93.1%

YTD Performance

BBNX-39.7%

CBLL10.9%

% from 52W High

BBNX-46.1%

CBLL-7.8%

% from 52W Low

BBNX100.3%

CBLL117.8%

Asset Turnover (TTM)

BBNX0.38x

CBLL0.55x

FCF Yield (TTM)

BBNX-7.7%

CBLL-6.3%

Earnings Yield (TTM)

BBNX-9.2%

CBLL-7.4%

Dividend Yield (TTM)

BBNXN/A

CBLLN/A

Rule of 40

BBNX42.5

CBLL-23.3

EV/GP/RG

BBNX0.34

CBLL0.28

Ticker research

View BBNX research View CBLL research

Metric	BBNX Beta Bionics Inc	CBLL Ceribell Inc
Market & Valuation
Market Cap	$793M	$897M
Enterprise Value	$749M	$884M
Price	$17.63	$23.63
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	8.79x
EV/Sales	6.29x	8.67x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.99x	7.09x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.19x	-15.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.37x	6.72x
Revenue & Growth
Revenue (TTM)	$119M	$102M
Revenue Growth (YoY)	94.1%	31.7%
Forward Rev Growth	34.2%	27.3%
Profitability
Gross Margin (TTM)	58.3%	88.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-67.9%	-67.5%
Net Margin (TTM)	-61.3%	-64.7%
FCF Margin (TTM)	-51.6%	-55.0%
Net Income (TTM)	$-73M	$-66M
FCF (TTM)	$-61M	$-56M
EPS (TTM)	-$1.64	-$1.74
ROE (TTM)	-2630.0%	-4485.0%
ROA (TTM)	-2325.0%	-3569.0%
ROIC (TTM)	-2630.0%	-3952.0%
Financial Health
Cash	$44M	$33M
Debt	$0	$20M
Net Cash/Debt	$44M	$13M
Current Ratio (TTM)	8.88x	9.18x
Quick Ratio (TTM)	7.72x	8.57x
Debt/Equity (TTM)	0.00x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	0.98
52W Performance	-20.3%	93.1%
YTD Performance	-39.7%	10.9%
% from 52W High	-46.1%	-7.8%
% from 52W Low	100.3%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.55x
FCF Yield (TTM)	-7.7%	-6.3%
Earnings Yield (TTM)	-9.2%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	-23.3
EV/GP/RG	0.34	0.28
Ticker research	View BBNX research	View CBLL research